$29.26
3.82% (Daily)
Market Cap
$4.21B
Revenue
$741.17M
Rank by MCap
#880
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Joseph K. Belanoff M.D.
Headquarters
Redwood City, CA
Employees
500
Corcept Therapeutics Incorporated engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
Loading chart…